High risk PCI

DEVICE2 trials

Sponsors

Abiomed Inc., Erasmus MC, Universitair Medisch Centrum Rotterdam

Conditions

Patients Undergoing High Risk PCI.heart disease Ischemic cardiomyopathy

Phase 2

PROTECT I, A Prospective Feasibility Trial Investigating the Use of IMPELLA RECOVER LP 2.5 System in Patients Undergoing High Risk PCI

CompletedNCT00534859

Abiomed Inc.Patients Undergoing High Risk PCI.

Start: 2006-08-31End: 2011-03-31Updated: 2011-03-21

Unknown Phase

PulseCath Mechanical Support Evaluation

RecruitingNL-OMON47268

Erasmus MC, Universitair Medisch Centrum Rotterdamheart disease Ischemic cardiomyopathy

Start: 2017-01-05Target: 20Updated: 2024-02-28

Related Papers

A prospective feasibility trial investigating the use of the Impella 2.5 system in patients undergoing high-risk percutaneous coronary intervention (The PROTECT I Trial): initial U.S. experience.

2009-02-01229 citations